Hepatocellular carcinoma screening
Hepatocellular carcinoma screening has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Oct 19, 2026: “Hepatocellular carcinoma screening in a tertiary hospital. What are we missing?”.
1 paper studies it2 findingsUpdated
1 new paper in 30 daysSee all 1
“Patients in subgroup (a) had HCC diagnosed at earlier stages (BCLC-0 and BCLC-A).”
None of its findings points the other way.
- 1 lab
- Humans1
What is Hepatocellular carcinoma screening linked with?
2Studies link Hepatocellular carcinoma screening with 2 measures, most often overall survival (1 study) and hepatocellular carcinoma stage at diagnosis (1).
Overall survival
upin humans1
1 study
Overall survival
upin humans1
Hepatocellular carcinoma screening is associated with overall survival in humans (patients with hepatocellular carcinoma; screened versus not diagnosed through screening).
“Overall survival was significantly higher for screened group.”
Humanspatients with hepatocellular carcinoma; screened versus not diagnosed through screening
Hepatocellular carcinoma screening in a tertiary hospital. What are we missing?
Oncology
Hepatocellular carcinoma stage at diagnosis
downin humans1
1 study
Hepatocellular carcinoma stage at diagnosis
downin humans1
Hepatocellular carcinoma screening is associated with hepatocellular carcinoma stage at diagnosis in humans (patients diagnosed through screening).
“Patients in subgroup (a) had HCC diagnosed at earlier stages (BCLC-0 and BCLC-A).”
Humanspatients diagnosed through screeningliver
Hepatocellular carcinoma screening in a tertiary hospital. What are we missing?
Oncology